Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia.

Intimal hyperplasia (IH) is the primary cause of vein bypass graft failure. The smooth muscle cell (SMC) is a key element of IH as it phenotypically switches from a contractile to a synthetic state which can become pathological. R7020, which is an engineered strain of Herpes Simplex Virus-1, inhibit...

Full description

Bibliographic Details
Main Authors: Susan McCormick, Qi He, Jordan Stern, Nikolai Khodarev, Ralph Weichselbaum, Christopher L Skelly
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4488439?pdf=render
_version_ 1828749720017698816
author Susan McCormick
Qi He
Jordan Stern
Nikolai Khodarev
Ralph Weichselbaum
Christopher L Skelly
author_facet Susan McCormick
Qi He
Jordan Stern
Nikolai Khodarev
Ralph Weichselbaum
Christopher L Skelly
author_sort Susan McCormick
collection DOAJ
description Intimal hyperplasia (IH) is the primary cause of vein bypass graft failure. The smooth muscle cell (SMC) is a key element of IH as it phenotypically switches from a contractile to a synthetic state which can become pathological. R7020, which is an engineered strain of Herpes Simplex Virus-1, inhibits IH in animal models. Although it has many characteristics which make it a strong candidate for use as a prophylactic agent how it inhibits IH is not well understood. The objective of this study was to identify modes of action used by R7020 to function in blood vessels that may also contribute to its inhibition of IH. The cytopathic effect of R7020 on SMCs was determined in vitro and in a rabbit IH model. In vitro assays with R7020 infected SMCs were used to quantify the effect of dose on the release kinetics of the virus as well as the effects of R7020 on cell viability and the adhesion of peripheral blood mononuclear cells (PBMCs) to SMCs in the absence and presence of tumor necrosis factor alpha (TNF-α). The observed cytopathic effect, which included R7020 positive filopodia that extend from cell to cell and the formation of syncytia, suggests that R7020 remains cell associated after egress and spreads cell to cell instead of by diffusion through the extracellular fluid. This would allow the virus to rapidly infect vascular cells while evading the immune system. The directionality of the filopodia in vivo suggests that the virus preferentially travels from the media towards the intima targeting SMCs that would lead to IH. The formation of syncytia would inhibit SMC proliferation as incorporated cells are not able to multiply. It was also observed that R7020 induced the fusion of PBMCs with syncytia suggesting the virus may limit the effect of macrophages on IH. Furthermore, R7020 inhibited the proliferative effect of TNF-α, an inflammatory cytokine associated with increased IH. Thus, the results of this study suggest that R7020 inhibits IH through multiple mechanisms.
first_indexed 2024-12-10T20:27:20Z
format Article
id doaj.art-d5c2251e82e040bf932568c798f43978
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T20:27:20Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-d5c2251e82e040bf932568c798f439782022-12-22T01:34:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01107e013026410.1371/journal.pone.0130264Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia.Susan McCormickQi HeJordan SternNikolai KhodarevRalph WeichselbaumChristopher L SkellyIntimal hyperplasia (IH) is the primary cause of vein bypass graft failure. The smooth muscle cell (SMC) is a key element of IH as it phenotypically switches from a contractile to a synthetic state which can become pathological. R7020, which is an engineered strain of Herpes Simplex Virus-1, inhibits IH in animal models. Although it has many characteristics which make it a strong candidate for use as a prophylactic agent how it inhibits IH is not well understood. The objective of this study was to identify modes of action used by R7020 to function in blood vessels that may also contribute to its inhibition of IH. The cytopathic effect of R7020 on SMCs was determined in vitro and in a rabbit IH model. In vitro assays with R7020 infected SMCs were used to quantify the effect of dose on the release kinetics of the virus as well as the effects of R7020 on cell viability and the adhesion of peripheral blood mononuclear cells (PBMCs) to SMCs in the absence and presence of tumor necrosis factor alpha (TNF-α). The observed cytopathic effect, which included R7020 positive filopodia that extend from cell to cell and the formation of syncytia, suggests that R7020 remains cell associated after egress and spreads cell to cell instead of by diffusion through the extracellular fluid. This would allow the virus to rapidly infect vascular cells while evading the immune system. The directionality of the filopodia in vivo suggests that the virus preferentially travels from the media towards the intima targeting SMCs that would lead to IH. The formation of syncytia would inhibit SMC proliferation as incorporated cells are not able to multiply. It was also observed that R7020 induced the fusion of PBMCs with syncytia suggesting the virus may limit the effect of macrophages on IH. Furthermore, R7020 inhibited the proliferative effect of TNF-α, an inflammatory cytokine associated with increased IH. Thus, the results of this study suggest that R7020 inhibits IH through multiple mechanisms.http://europepmc.org/articles/PMC4488439?pdf=render
spellingShingle Susan McCormick
Qi He
Jordan Stern
Nikolai Khodarev
Ralph Weichselbaum
Christopher L Skelly
Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia.
PLoS ONE
title Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia.
title_full Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia.
title_fullStr Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia.
title_full_unstemmed Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia.
title_short Evidence for the Use of Multiple Mechanisms by Herpes Simplex Virus-1 R7020 to Inhibit Intimal Hyperplasia.
title_sort evidence for the use of multiple mechanisms by herpes simplex virus 1 r7020 to inhibit intimal hyperplasia
url http://europepmc.org/articles/PMC4488439?pdf=render
work_keys_str_mv AT susanmccormick evidencefortheuseofmultiplemechanismsbyherpessimplexvirus1r7020toinhibitintimalhyperplasia
AT qihe evidencefortheuseofmultiplemechanismsbyherpessimplexvirus1r7020toinhibitintimalhyperplasia
AT jordanstern evidencefortheuseofmultiplemechanismsbyherpessimplexvirus1r7020toinhibitintimalhyperplasia
AT nikolaikhodarev evidencefortheuseofmultiplemechanismsbyherpessimplexvirus1r7020toinhibitintimalhyperplasia
AT ralphweichselbaum evidencefortheuseofmultiplemechanismsbyherpessimplexvirus1r7020toinhibitintimalhyperplasia
AT christopherlskelly evidencefortheuseofmultiplemechanismsbyherpessimplexvirus1r7020toinhibitintimalhyperplasia